BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7095141)

  • 1. [Syntheses designed to produce 8-amino ellipticine. Synthesis and pharmacological properties of 8-nitro ellipticine].
    Gansser C; Lévque X; Plat M; Viel C
    Farmaco Sci; 1982 May; 37(5):283-97. PubMed ID: 7095141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [9-Nitro- and 9-amino-ellipticines and derivatives: synthesis and pharmacologic properties].
    Gansser C; Viel C; Malvy C; Cros S
    Farmaco Sci; 1980 Nov; 35(11):887-95. PubMed ID: 7450021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 4-amino-substituted 7-methoxy (and 7-hydroxy)- 11-methyl (and 5,11-dimethyl)-10H-pyrido [2,3-b] carbazoles and 4-amino- substituted 11-methyl (and 5,11-dimethyl)-10H-pyrido[3',4':4,5] pyrrolo [3,2-g] quinolines, two new series related to antitumor ellipticine derivatives.
    Moron J; Rautureau M; Huel C; Pierré A; Berthier LK; Atassi G; Bisagni E
    Anticancer Drug Des; 1993 Dec; 8(6):399-416. PubMed ID: 8286009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives.
    Ducrocq C; Wendling F; Tourbez-Perrin M; Rivalle C; Tambourin P; Pochon F; Bisagni E; Chermann JC
    J Med Chem; 1980 Nov; 23(11):1212-6. PubMed ID: 7452670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of ellipticine and aza-analogue derivatives on cell cycle progression and survival of BALB/c 3T3 cells released from serum starvation or thymidine double block.
    Vilarem MJ; Charcosset JY; Primaux F; Gras MP; Calvo F; Larsen CJ
    Cancer Res; 1985 Aug; 45(8):3906-11. PubMed ID: 4016757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effects of the lysosomotropic agents DNA-ellipticine, DNA-daunorubicin, and DNA-ellipticine:daunorubicin on L1210 leukemia cells.
    Sorace RA; Sheid B
    Cancer Treat Rep; 1979 Jan; 63(1):43-51. PubMed ID: 421232
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of ellipticine on cell survival and cell cycle progression in cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1980 Jul; 40(7):2390-9. PubMed ID: 6155993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,4-Dimethyl-6 H-pyrido[3,2-b]carbazole, an isomer of the antitumor alkaloid ellipticine via the Combes-Beyer reaction.
    Alunni-Bistocchi G; Orvietani P; Bittoun P; Ricci A; Lescot E
    Pharmazie; 1993 Nov; 48(11):817-20. PubMed ID: 8295911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basically substituted ellipticine analogues as potential antitumor agents.
    Werbel LM; Angelo M; Fry DW; Worth DF
    J Med Chem; 1986 Jul; 29(7):1321-2. PubMed ID: 3806584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ellipticine, 9-hydroxyellipticine, and 9-hydroxyellipiticinum: some biochemical properties of possible pharmacologic significance.
    Paoletti C; Auclair C; Lesca P; Tocanne JF; Malvy C; Pinto M
    Cancer Treat Rep; 1981; 65 Suppl 3():107-18. PubMed ID: 7049365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of new 1-phenyl-6H-pyrido[4,3-b]carbazole derivatives with potential cytostatic activity.
    Tylińska B; Jasztold-Howorko R; Mastalarz H; Szczaurska-Nowak K; Materek P; Wietrzyk J
    Acta Pol Pharm; 2011; 68(1):31-7. PubMed ID: 21485699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA binding ellipticine analogues: synthesis, biological evaluation, and structure-activity relationships.
    Ferlin MG; Marzano C; Gandin V; Dall'Acqua S; Dalla Via L
    ChemMedChem; 2009 Mar; 4(3):363-77. PubMed ID: 19197924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological properties of derivatives of isoxazolo [5,4-d]-6,7-dihydropyrimidines.
    Machoń Z; Ryng S
    Pol J Pharmacol Pharm; 1988; 40(2):209-16. PubMed ID: 3237570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage and cytotoxicity in L1210 cells by ellipticine and a structural analogue, N-2-(diethylaminoethyl)-9-hydroxyellipticinium chloride.
    Djuric Z; Everett CK; Valeriote FA
    Cancer Res; 1992 Mar; 52(6):1515-9. PubMed ID: 1540960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA-polyintercalation compounds. Synthesis of ellipticine dimers].
    Delbarre A; Roques BP; le Pecq JB
    C R Acad Hebd Seances Acad Sci D; 1977 Jan; 284(1):81-4. PubMed ID: 402233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sanguinarine and ellipticine cytotoxic alkaloids isolated from well-known antitumor plants. Intracellular targets of their action].
    Faddeeva MD; Beliaeva TN
    Tsitologiia; 1997; 39(2-3):181-208. PubMed ID: 9312909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding to DNA, cellular uptake and biological activity of a distamycin-ellipticine hybrid molecule.
    Bailly C; Leclere V; Pommery N; Colson P; Houssier C; Rivalle C; Bisagni E; Hénichart JP
    Anticancer Drug Des; 1993 Apr; 8(2):145-64. PubMed ID: 8494604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative way of the synthesis of 1-substituted 9-methoxy-5-methyl-6H-pyrido[4,3-b]carbazole derivatives.
    Jasztold-Howorko R; Croisy A; Carrez D
    Acta Pol Pharm; 2005; 62(3):207-12. PubMed ID: 16193813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitumor activity of quaternary ellipticine glycosides, a series of novel and highly active antitumor agents.
    Honda T; Kato M; Inoue M; Shimamoto T; Shima K; Nakanishi T; Yoshida T; Noguchi T
    J Med Chem; 1988 Jul; 31(7):1295-305. PubMed ID: 3385725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective synthesis of 9-hydroxyellipticine glycosides, novel and highly active antitumor agents.
    Honda T; Inoue M; Kato M; Shima K; Shimamoto T
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3975-8. PubMed ID: 3435996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.